Tykerb, a once daily pill, was approved by the FDA last month as a tool to help treat breast cancer. It's designed for women who have an aggressive form of breast cancer, called her-2 positive when it has metastasized or spread. The FDA approval of Tykerb is allowing a new form of treatment for women who have advanced stages of breast cancer. Doctors say it's an important step in the treatment for women with breast cancer. The pill is designed to be taken once daily in conjunction with the chemotherapy drug Xeloda. In the past women in the advanced stages of breast cancer who progressed even after the drug herceptin had few other options. Tykerb works from inside the cell to slow or stop the process that causes tumor growth and disease progression. It can also offer other benefits for cancer patients. Doctor Miller says women who have cardiac disfunction must be monitored closely because of a small, but significant risk of heart problems. A step in the right direction to help women in the ongoing battle with breast cancer. Tykerb is now available locally. Dr. Miller says your doctor should decide if it's the right treatment for you.